Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Current Liabilities (2020 - 2022)

Historic Total Current Liabilities for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $15.6 million.

  • Atea Pharmaceuticals' Total Current Liabilities fell 9403.4% to $15.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $15.6 million, marking a year-over-year decrease of 9403.4%. This contributed to the annual value of $56.9 million for FY2021, which is 8198.74% down from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Total Current Liabilities of $15.6 million as of Q3 2022, which was down 9403.4% from $25.1 million recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Total Current Liabilities high stood at $315.8 million for Q4 2020, and its period low was $10.8 million during Q3 2020.
  • Its 3-year average for Total Current Liabilities is $138.1 million, with a median of $56.9 million in 2021.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 232281.8% in 2021, then plummeted by 9403.4% in 2022.
  • Atea Pharmaceuticals' Total Current Liabilities (Quarter) stood at $315.8 million in 2020, then tumbled by 81.99% to $56.9 million in 2021, then crashed by 72.52% to $15.6 million in 2022.
  • Its Total Current Liabilities was $15.6 million in Q3 2022, compared to $25.1 million in Q2 2022 and $28.6 million in Q1 2022.